Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$15M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 8 most recent Form 4 transactions.
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 411,750 | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 14.8M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | PBUY | 22,545 | $18.00 | $405.8K | +16.7% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 134,842 | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | PBUY | 812,455 | $18.00 | $14.6M | +16.7% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 4.9M | — | — | — | Open the original filing on SEC.gov |